Table 4. Prevalence of Controlled Triglycerides (<150 mg/dL) among Adults with Diabetes-NHANES 1999-2014.
Variables |
Overall (n=2750) |
1999-2002 (n=454) |
2003-2006 (n=543) |
2007-2010 (n=910) |
2011-2014 (n=843) |
Ptrend (adjusted) |
|---|---|---|---|---|---|---|
All patients |
53.0 (1.5) |
45.4 (2.9) |
47.6 (2.9) |
55.8 (2.1) |
58.8 (3.5) |
<0.001 |
Race and ethnicity |
||||||
Whites |
50.8 (1.6) |
43.0 (1.1) |
47.5 (1.4) |
54.6 (1.5) |
56.9 (2.3) |
0.02 |
Blacks |
72.4 (0.8) |
62.4 (1.5) |
68.6 (1.9) |
72.9 (2.2) |
79.9 (2.5) |
<0.01 |
Hispanics |
47.8 (0.8) |
49.6 (3.0) |
42.7 (2.2) |
45.9 (1.9) |
51.5 (1.9) |
0.53 |
Others |
47.5 (0.5) |
41.9 (3.2) |
45.5 (1.1) |
56.0 (4.0) |
54.8 (3.4) |
0.15 |
Education |
||||||
Less than high school |
50.2 (0.8) |
44.4 (3.6) |
47.2 (3.4) |
48.1 (3.7) |
58.7 (4.1) |
0.03 |
High school graduate |
51.8 (0.9) |
45.5 (5.7) |
47.0 (4.5) |
57.5 (3.0) |
57.8 (4.4) |
0.02 |
Some college |
53.0 (1.0) |
38.9 (1.1) |
49.2 (1.8) |
55.7 (1.6) |
59.0 (2.8) |
<0.01 |
College graduate or above |
59.0 (0.9) |
58.6 (1.9) |
50.8 (2.2) |
65.4 (3.0) |
59.6 (3.1) |
0.64 |
Poverty-to-income ratio (PIR) |
||||||
<100% |
47.8 (0.7) |
32.0 (1.3) |
40.1 (1.6) |
49.0 (1.2) |
51.0 (2.5) |
0.01 |
100%-299% |
54.5 (1.3) |
50.9 (1.5) |
49.5 (1.8) |
54.7 (1.4) |
60.9 (2.0) |
0.14 |
300%-499% |
51.0 (1.0) |
41.2 (1.6) |
45.0 (2.1) |
58.5 (2.0) |
51.3 (2.7) |
0.12 |
≥500% |
57.0 (1.1) |
52.8 (1.9) |
60.4 (2.2) |
66.9 (3.6) |
68.4 (4.3) |
0.02 |
Insurance |
||||||
Insured |
58.2 (0.5) |
47.0 (0.9) |
49.3 (1.1) |
56.9 (1.1) |
60.8 (1.6) |
0.02 |
Uninsured |
45.0 (1.6) |
42.5 (2.2) |
36.7 (1.7) |
50.5 (1.8) |
49.2 (1.8) |
0.54 |
Statin use |
||||||
Yes |
56.1 (1.1) |
49.5 (3.0) |
54.5 (1.2) |
57.1 (1.3) |
64.2 (1.2) |
0.02 |
No |
51.2 (1.0) |
43.8 (1.1) |
46.8 (1.0) |
52.6 (1.1) |
51.4 (1.3) |
0.13 |
Diabetes Medication |
||||||
Oral medications only |
52.3 (1.5) |
40.9 (0.9) |
46.5 (1.3) |
53.5 (1.3) |
61.6 (2.1) |
0.03 |
Insulin |
67.1 (0.7) |
69.5 (1.8) |
56.2 (2.7) |
61.3 (3.9) |
68.0 (4.2) |
0.55 |
Oral medication and insulin |
51.5 (0.6) |
37.8 (1.2) |
43.5 (2.9) |
52.3 (3.4) |
51.9 (3.4) |
0.50 |
None |
54.9 (1.0) |
50.9 (2.5) |
49.4 (2.1) |
59.8 (2.4) |
55.9 (2.4) |
0.44 |
Co-morbidities |
||||||
Hypertension |
53.4 (1.3) |
45.4 (1.0) |
48.2 (1.1) |
54.9 (1.1) |
59.5 (1.6) |
0.03 |
Chronic Kidney Disease |
56.3 (1.4) |
46.4 (1.6) |
56.3 (1.9) |
61.3 (1.5) |
64.7 (2.2) |
<0.001 |
Cardiovascular disease |
52.2 (0.9) |
40.1 (1.5) |
49.1 (1.7) |
55.8 (1.5) |
55.9 (1.9) |
0.02 |
Albuminuria |
46.9 (1.4) |
36.9 (1.0) |
43.7 (1.1) |
52.6 (1.2) |
50.4 (1.5) |
0.10 |
Data are presented as percentages and Standard Error (SE) | ||||||